References
- Speroff L, Fritz MA. Kliniczna Endokrynologia Ginekologiczna i Niepłodność. 1st ed. Warsaw: Medipage; 2007. p. 187–188. 1419–1448.
- Kociszewska K. Osie hormonalne zależne od GnRH. Annales Academiae Medicae Silesiensis. 2011;65:5–6. 54–60.
- Djerassy A, Coutifaris C, West VA. Gonadotrophin adenoma in a premenopausal woman secreting follicle stimulating hormone and causing ovarian hyperstimulation. J Clin Endocrynol Metab. 1995;80:591–594.
- Chanson P, Schaison G. Pituitary apoplexy caused by GnRH-agonist treatment revealing gonadotroph adenoma. And Letters to the editor. J Clin Endocrynol Metab. 1995;80:2267–2268.
- Kovacs M, Schally AV. Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist triptorelin on the gene expression of pituitary LHRH receptors in rats. Proc Natl Acad Sci USA. 2001;98(21):12197–12202.
- Han J, Zhang S, Liu W, et al. An analytical strategy to characterize the pharmacokinetics and pharmacodynamics of triptorelin in rats based on simultaneous LC–MS/MS analysis of triptorelin and endogenous testosterone in rat plasma. Anal Bioanal Chem. 2014;406(9–10):2457–2465.
- Jachman-Kapułka J, Mariańska K. Udar niedokrwienny w obszarze gruczolaka gonadotropowego przysadki [Ischemic stroke in the area of pituitary gonadotropic adenoma]. Polski Przegląd Neurologiczny. [Polish Neurological Review]. 2014;10(4):161–168.
- Wagar M, Karabatsou K, Kearney T, et al. Classical pituitary apoplexy. Br J Hosp Med. 2019;80:114.